Business Description
Cizzle Biotechnology Holdings PLC
ISIN : GB00BNG2VN02
Description
Cizzle Biotechnology Holdings PLC is in the early stages of developing a blood test for the early detection of a majority of the different forms of lung cancer. Its proof-of-concept prototype test is based on the ability to detect a stable plasma biomarker, a variant of C1Z1 known as CIZ1B. C1Z1 is a naturally occurring cell nuclear protein involved in DNA replication, and the targeted C1Z1B variant is highly correlated with early stage lung cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.95 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -44.2 | |||||
| 3-Year Book Growth Rate | 100 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.47 | |||||
| 9-Day RSI | 33.49 | |||||
| 14-Day RSI | 35.2 | |||||
| 6-1 Month Momentum % | 25 | |||||
| 12-1 Month Momentum % | -28.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.18 | |||||
| Quick Ratio | 5.18 | |||||
| Cash Ratio | 3.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.3 | |||||
| Shareholder Yield % | -4.45 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -36.84 | |||||
| ROA % | -35.08 | |||||
| ROIC % | -43.91 | |||||
| ROC (Joel Greenblatt) % | -1080.65 | |||||
| ROCE % | -38.85 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 1.7 | |||||
| PE Ratio without NRI | 1.7 | |||||
| PB Ratio | 2.43 | |||||
| EV-to-EBIT | -5.83 | |||||
| EV-to-Forward-EBIT | -3.38 | |||||
| EV-to-EBITDA | -5.83 | |||||
| EV-to-Forward-EBITDA | -3.64 | |||||
| EV-to-FCF | -7.64 | |||||
| Earnings Yield (Greenblatt) % | -17.15 | |||||
| FCF Yield % | -11.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cizzle Biotechnology Holdings PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | |||
| EPS (TTM) (£) | 0.01 | ||
| Beta | 0 | ||
| Volatility % | 69.96 | ||
| 14-Day RSI | 35.2 | ||
| 14-Day ATR (£) | 0.00134 | ||
| 20-Day SMA (£) | 0.018288 | ||
| 12-1 Month Momentum % | -28.57 | ||
| 52-Week Range (£) | 0.0161 - 0.037 | ||
| Shares Outstanding (Mil) | 396.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cizzle Biotechnology Holdings PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cizzle Biotechnology Holdings PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cizzle Biotechnology Holdings PLC Frequently Asked Questions
What is Cizzle Biotechnology Holdings PLC(LSE:CIZ)'s stock price today?
The current price of LSE:CIZ is £0.02. The 52 week high of LSE:CIZ is £0.04 and 52 week low is £0.02.
When is next earnings date of Cizzle Biotechnology Holdings PLC(LSE:CIZ)?
The next earnings date of Cizzle Biotechnology Holdings PLC(LSE:CIZ) is 2024-04-26 Est..
Does Cizzle Biotechnology Holdings PLC(LSE:CIZ) pay dividends? If so, how much?
Cizzle Biotechnology Holdings PLC(LSE:CIZ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers